Skip to main content
SpringerLink
Log in

Markers and Immunoprofile of Mastocytosis

  • Chapter
  • First Online:
Immunohistochemistry in Tumor Diagnostics

  • 2713 Accesses

Abstract

Mast cell tryptase, CD117, CD2, CD25, CD30, and CD33 [1–6], [ 10]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hoyer JD, Grogg KL, Hanson CA, et al. CD33 detection by immunohistochemistry in paraffin-embedded tissues. A new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage. Am J Clin Pathol. 2008;129:316–23.

    Article  PubMed  Google Scholar 

  2. Jordan JH, Walchshofer S, Jurecka W, et al. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: Evidence for expression of CD2, CD117/Kit, and bcl-xL. Hum Pathol. 2001;32:545–52.

    Article  CAS  PubMed  Google Scholar 

  3. van Daele PLA, Beukenkamp BS, Geertsma-Kleinekoort WMC, et al. Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis. Neth J Med. 2009;67:142–6.

    PubMed  Google Scholar 

  4. Horny HP, Sotlar K, Valent P. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review. Pathobiology. 2010;77(4):169–80.

    Article  PubMed  Google Scholar 

  5. Sotlar K, Cerney-Reiterer S, Petet-Dutter K, et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol. 2011;24(4):585–95.

    Article  CAS  PubMed  Google Scholar 

  6. van Anrooij B, Kluin PM, Oude Elberink JN, el al. CD30 in systemic mastocytosis. Immunol Allergy Clin N Am 2014;34(2):341-355.

    Google Scholar 

  7. Hahn HP, Hornick JL. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol. 2007;31(11):1669–76.

    Article  PubMed  Google Scholar 

  8. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision of the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Carl-Thiem-Klinikum, Institut für Pathologie, Cottbus, Germany

    Muin S. A. Tuffaha

  2. Vivantes Klinikum Neukölln, Institut für Pathologie, Berlin, Germany

    Hans Guski

  3. Universität Bonn, UKB, Institut für Pathologie, Bonn, Germany

    Glen Kristiansen

Authors
  1. Muin S. A. Tuffaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Guski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Glen Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Tuffaha, M.S.A., Guski, H., Kristiansen, G. (2018). Markers and Immunoprofile of Mastocytosis. In: Immunohistochemistry in Tumor Diagnostics. Springer, Cham. https://doi.org/10.1007/978-3-319-53577-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53577-7_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53576-0

  • Online ISBN: 978-3-319-53577-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation